NGM Biopharmaceuticals

-$0.18 (-0.94%) As of 4:02 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NGM and other ETFs, options, and stocks.

About NGM

NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its lead product candidate, aldafermin, is designed for the treatment of patients with non-alcoholic steatohepatitis, with liver fibrosis stage 2, 3, or 4.

CEO
David J. Woodhouse
Employees
210
Headquarters
South San Francisco, California
Founded
2007

NGM Key Statistics

Market Cap
1.47B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
324.53K
High Today
$19.31
Low Today
$18.86
Open Price
$19.31
Volume
39.13K
52 Week High
$32.12
52 Week Low
$14.90

NGM Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure